Minerva Neurosciences, INC. (NERV) SEC Filings — 2024
16 SEC filings for Minerva Neurosciences, INC. (NERV) in 2024.
Filings
- Minerva Neurosciences Files 8-K on Shareholder Votes — 8-K · Dec 5, 2024
- Minerva Neurosciences, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Minerva Neurosciences Files Q3 2024 10-Q — 10-Q · Nov 5, 2024
- Minerva Neurosciences Files Definitive Proxy Statement — DEF 14A · Oct 22, 2024
- Minerva Neurosciences Faces Delisting Concerns — 8-K · Oct 11, 2024
- Minerva Neurosciences Files 8-K — 8-K · Sep 16, 2024
- Minerva Neurosciences Files Q2 2024 10-Q — 10-Q · Aug 6, 2024
- Minerva Neurosciences Announces Board and Executive Changes — 8-K · May 30, 2024
- Minerva Neurosciences Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 1, 2024
- Minerva Neurosciences Files Amended 10-K for Fiscal Year Ended Dec 31, 2023 — 10-K/A · Apr 22, 2024
- Minerva Neurosciences Faces Nasdaq Delisting Warning — 8-K · Apr 12, 2024
- Minerva Neurosciences Files 8-K for Other Events & Exhibits — 8-K · Feb 27, 2024
- Minerva Neurosciences Files Amended 10-K for Fiscal Year Ended December 31, 2023 — 10-K/A · Feb 26, 2024
- Minerva Neurosciences Files 2023 Annual Report on Form 10-K — 10-K · Feb 22, 2024
- FMR LLC Discloses 7.031% Passive Stake in Minerva Neurosciences — SC 13G · Feb 9, 2024
- Federated Hermes Amends Minerva Neurosciences Stake (13G/A) — SC 13G/A · Jan 18, 2024